ATAI
shows an improved therapeutic index in preclinical studies and in a pilot third party clinical trial and may demonstrate effects through different mechanisms racemate differentiated profiles with found to have greater potency animal models | ATAI
Company
Deck Type
Sector
Industry
Deck date
October 2022
Slide
11 of 41
Related slides by other companies
Exscientia
Investor Presentation
August 2023
malt exs | Exscientia
Exscientia
Investor Presentation
March 2024
precision designed to therapeutic index | Exscientia
Exscientia
Investor Presentation
July 2023
malt exs | Exscientia
Exscientia
Investor Presentation
October 2023
malt exs | Exscientia
Other recent decks by ATAI
See all presentations (13 decks)
Investor Presentation
January 2024
Investor Presentation
October 2023
Investor Conference
May 2023
Investor Presentation
April 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io